There is plenty of evidence that people who have recovered from COVID-19 have protection against reinfection, Rep. Diana Harshbarger (R-Tenn.) said. “There’s ample scientific studies that show that natural immunity is absolutely one of the best things you could have—and some studies even show that it’s more effective [than vaccination],” Harshbarger said during a recent appearance…
‘Ample Scientific Data’: Congresswoman Introduces ‘Natural Immunity Is Real Act’
2 New Studies Test Quercetin and COVID-19 Outcomes
Since the beginning of the COVID-19 pandemic, good doctors have done what good doctors do and have given their patients safe and effective therapeutics to treat COVID-19. While public health officials said nothing could be done, many doctors applied lessons learned from previous viral infections and helped their patients support their immune systems with safe…
Rep. Biggs: Federal COVID-19 Vaccine Mandates Triggering ‘Tremendous Pushback’
President Joe Biden’s federal COVID-19 vaccine mandates are unconstitutional and the mandates and other actions by his administration are triggering strong challenges, legal and otherwise, Rep. Andy Biggs (R-Ariz.) said. Biden last month imposed a vaccine mandate on federal workers and contractors, with limited exceptions, and his administration plans to force private businesses to compel…
Insurance Focused on Virtual Visits?
At the height of the COVID-19 pandemic, people often relied on telemedicine for doctor visits. Now insurers are betting that some patients liked it enough to embrace new types of health coverage that encourage video visits—or that outright insist on them. Priority Health in Michigan, for example, offers coverage requiring online visits first for nonemergency…
COVID-19 Antiviral Pill From Roche, Atea Fails to Help Patients With Mild or Moderate Symptoms
A pill developed by two drugmakers failed to help COVID-19 patients with mild or moderate symptoms, one of the companies announced Tuesday. Atea Pharmaceuticals and Roche tested their experimental treatment in a Phase 2 trial in outpatient settings, or non-hospitalized patients. The study failed to meet the primary endpoint, which was a reduction in the…
Appeals Court Refuses to Stop Maine Vaccine Mandate, Organization Mulls Turning to Supreme Court
The 1st U.S. Circuit Court of Appeals on Friday refused to issue an emergency injunction to stop Maine’s COVID-19 vaccine mandate. The three-judge panel of the Boston-based court issued a one-sentence statement saying the request was denied without an explanation, The Bangor Daily News reported. A final ruling will likely be issued next week, according…
US Set to Pay $712 Per Patient for Merck’s COVID-19 Pill
Merck is set to get $712 per treatment course for its COVID-19 pill from the U.S. government—even as it costs a fraction of that to produce, and is reportedly on track for a price of $12 in India. The gap between production costs and the price for molnupiravir is gigantic and emblematic of a problem…
Second Dose of Johnson & Johnson COVID-19 Vaccine Recommended for All US Adults
Every adult 18 and older in the United States who received the single-shot Johnson & Johnson COVID-19 vaccine will be able to get a booster dose if the Food and Drug Administration (FDA) accepts a recommendation from its advisory panel. The panel unanimously voted Friday to advise the agency to authorize boosters for all adults,…
Walgreens Responds After Family Says Children Received COVID-19 Vaccine Instead of Flu Shot
Walgreens issued a statement saying vaccine mix-ups are rare after an Indiana family said their two young children got two full adult doses of the Pfizer COVID-19 vaccine instead of influenza shots. Speaking to 14News, Alexandra and Joshua Price said a Walgreens in Evansville, Indiana, administered the COVID-19 vaccines to their two young children, aged 4…
FDA Panel Unanimously Recommends Authorization of Moderna COVID-19 Vaccine Booster
A Food and Drug Administration (FDA) advisory panel voted unanimously on Thursday to recommend the agency let millions of Americans get a booster of Moderna’s COVID-19 vaccine. The 19–0 vote came after hours of discussions and presentations in an all-virtual meeting. Moderna officials presented data from clinical trials, including a small trial that studied the…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta